Expert Opinion on Drug Delivery

Scope & Guideline

Bridging Research and Application in Pharmaceutical Science

Introduction

Immerse yourself in the scholarly insights of Expert Opinion on Drug Delivery with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1742-5247
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2004 to 2024
AbbreviationEXPERT OPIN DRUG DEL / Expert Opin. Drug Deliv.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The journal 'Expert Opinion on Drug Delivery' focuses on the innovative and effective delivery of pharmaceutical agents through various systems and methods. It aims to explore the evolving landscape of drug delivery technologies, particularly emphasizing nanotechnology and advanced formulations that enhance therapeutic outcomes.
  1. Nanotechnology in Drug Delivery:
    The journal extensively covers the application of nanotechnology for drug delivery systems, including nanoparticles, liposomes, and nanocarriers that improve the efficacy of treatments and target specific tissues.
  2. Innovative Formulation Strategies:
    It discusses various formulation strategies such as 3D printing, microencapsulation, and hydrogels that facilitate the controlled and sustained release of therapeutics.
  3. Biologics and Biopharmaceuticals:
    The journal emphasizes the delivery of biologics, including monoclonal antibodies and nucleic acids, focusing on overcoming biological barriers to enhance their therapeutic effectiveness.
  4. Targeted and Personalized Medicine:
    There is a strong focus on targeted drug delivery systems that customize treatments based on patient-specific factors, enhancing the precision of therapies.
  5. Clinical Applications and Trials:
    The journal includes insights from clinical trials that evaluate the effectiveness of new drug delivery systems, providing a bridge between laboratory research and clinical practice.
The journal 'Expert Opinion on Drug Delivery' has identified several emerging themes in drug delivery research, reflecting the ongoing advancements in technology and the growing need for innovative solutions. These trends indicate the journal's responsiveness to the evolving landscape of drug delivery.
  1. Personalized Medicine and Tailored Therapies:
    There is an increasing focus on personalized medicine, with research exploring how drug delivery systems can be customized to individual patient profiles, improving therapeutic outcomes and minimizing adverse effects.
  2. Smart Drug Delivery Systems:
    Emerging themes include the development of smart and responsive drug delivery systems that utilize stimuli such as pH, temperature, or specific biomarkers to release drugs at the right time and place.
  3. Combination Therapies:
    There is a notable trend towards exploring combination therapies, where drug delivery systems are designed to co-deliver multiple therapeutic agents, enhancing treatment efficacy especially in cancer and chronic diseases.
  4. Regenerative Medicine and Tissue Engineering:
    Research is increasingly focusing on drug delivery systems that support regenerative medicine, including the use of scaffolds and hydrogels to deliver therapeutic agents for tissue repair and healing.
  5. Innovations in Inhalation and Nasal Delivery:
    Recent publications reflect a growing interest in advanced inhalation and nasal delivery systems for providing targeted therapy for respiratory diseases, showcasing innovative formulations that enhance bioavailability.

Declining or Waning

While 'Expert Opinion on Drug Delivery' consistently explores a wide range of drug delivery technologies, certain themes have shown a decline in frequency or relevance over the recent years. This section highlights those waning scopes.
  1. Traditional Drug Delivery Methods:
    There is a noticeable decline in articles focused on conventional drug delivery methods, such as oral and intravenous routes, as the emphasis has shifted towards more innovative and technologically advanced delivery systems.
  2. Non-targeted Delivery Systems:
    Research on non-targeted or generalized drug delivery systems is becoming less prominent, as the field increasingly prioritizes targeted approaches that enhance specificity and minimize side effects.
  3. Basic Pharmacokinetics Studies:
    Basic studies on pharmacokinetics are being replaced by more complex models that incorporate advanced drug delivery systems, indicating a waning interest in traditional pharmacokinetic research.

Similar Journals

Current Drug Delivery

Exploring the forefront of therapeutic advancements.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1567-2018Frequency: 10 issues/year

Current Drug Delivery, published by Bentham Science Publishers Ltd, serves as a vital platform for advancing the field of pharmaceutical sciences. With an ISSN of 1567-2018 and an E-ISSN of 1875-5704, this esteemed journal focuses on all aspects of drug delivery systems, encompassing innovative research and developments that aim to improve therapeutics and patient outcomes. Operating from the United Arab Emirates, it has an impressive standing reflected in its 2023 Q2 ranking in Pharmaceutical Sciences and a notable position within the 62nd percentile in Scopus’s Pharmacology, Toxicology, and Pharmaceutics category. The journal not only acts as an essential resource for researchers and professionals but it also encourages the dissemination of knowledge among students and budding scientists. With the latest articles and reviews converging from 2004 to 2024, Current Drug Delivery remains committed to offering high-quality content that enhances understanding and sparks innovation in drug delivery mechanisms.

International Journal of Pharmacology

Empowering Scholars to Shape the Future of Pharmacology
Publisher: ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINETISSN: 1811-7775Frequency: 8 issues/year

Welcome to the International Journal of Pharmacology, a key publication in the field of pharmacology, published by ASIAN NETWORK SCIENTIFIC INFORMATION (ANSINET). Since its inception in 2006, this journal has provided a vital platform for researchers and professionals to disseminate their findings and insights in pharmacology, toxicology, and pharmaceutics. Despite recent discontinuation in Scopus coverage, the journal's dedication to fostering scientific dialogue continues to attract contributions from esteemed scholars globally. With an **ISSN of 1811-7775** and **E-ISSN of 1812-5700**, the journal seeks to bridge the gap between laboratory research and clinical application, promoting a deeper understanding of drug actions and interactions. Although it operates under traditional access options, the relevance of its published studies to ongoing pharmacological research remains significant.

Asian Journal of Pharmaceutics

Connecting researchers to the forefront of pharmaceutical innovation.
Publisher: ASIAN JOURNAL PHARMACEUTICSISSN: 0973-8398Frequency: 4 issues/year

Asian Journal of Pharmaceutics, with ISSN 0973-8398 and E-ISSN 1998-409X, is a prominent publication in the field of pharmacology, toxicology, and pharmaceutics, published by the ASIAN JOURNAL PHARMACEUTICS. Since its inception in 2009, the journal has been committed to advancing the understanding of pharmaceutical sciences in Asia and beyond, encompassing innovative research, reviews, and perspectives from both established and emerging scholars. Despite its coverage discontinuation in Scopus, it continues to serve as a vital resource for researchers, professionals, and students aiming to explore the dynamic developments in drug formulation, delivery systems, and regulatory affairs. The journal's ranking in the 18th percentile within its category underscores its niche focus and relevance, making it an essential conduit for disseminating knowledge in the pharmaceutical domain. Open access options may enhance its reach and impact, allowing significant findings to be freely accessible to a global audience, thus fostering collaboration and knowledge exchange across borders.

Journal of Pharmaceutical Investigation

Shaping the landscape of pharmaceutical investigation and discovery.
Publisher: SPRINGERNATUREISSN: 2093-5552Frequency: 6 issues/year

Journal of Pharmaceutical Investigation, published by SPRINGERNATURE, is a leading academic resource in the field of pharmaceutical sciences, offering critical insights and innovative research findings. With an impact factor that underscores its significance, this journal ranks in the Q1 category for both Pharmacology and Pharmaceutical Science as of 2023, showcasing its high-quality publications and rigorous peer-review processes. Operating from the Netherlands, the journal spans from 2012 to 2024, offering a rich archive of interdisciplinary research contributions that advance knowledge in pharmacology, toxicology, and pharmaceutics. It holds impressive Scopus rankings, placing it among the top-tier journals in its categories, which enhances its appeal to researchers, professionals, and students aiming to publish their work or stay up-to-date with the latest advancements in the pharmaceutical field. Engaging with the Journal of Pharmaceutical Investigation not only enriches your understanding but also connects you with a community dedicated to advancing healthcare and therapeutic innovations.

SCIENTIA PHARMACEUTICA

Transforming knowledge into practice in the pharmaceutical field.
Publisher: MDPIISSN: Frequency: 4 issues/year

SCIENTIA PHARMACEUTICA, published by MDPI in Switzerland, is a leading open access journal dedicated to advancing the field of pharmaceutical sciences since 2006. With a focus on pharmacology, toxicology, and pharmaceutics, this journal plays a pivotal role in disseminating high-quality research and innovative findings. It boasts an impressive impact factor and is ranked in the second quartile (Q2) for Pharmaceutical Science, signifying its influence within the academic community, aided by a Scopus ranking of 74 out of 183 journals in the same category. SCIENTIA PHARMACEUTICA invites original research articles, reviews, and notes that contribute to the understanding and development of pharmaceutical science, making it an essential resource for researchers, professionals, and students alike seeking to stay at the forefront of this continuously evolving field. For those interested in broadening their knowledge and sharing insights, the journal ensures wide accessibility, supporting the open access model for maximum outreach.

PHARMACEUTICAL RESEARCH

Driving discoveries that shape the future of medicine.
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0724-8741Frequency: 12 issues/year

PHARMACEUTICAL RESEARCH, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal in the ever-evolving field of pharmaceutical sciences. With an ISSN of 0724-8741 and an E-ISSN of 1573-904X, this journal has established itself as a critical hub for disseminating innovative research from 1984 to 2024. The journal holds impressive rankings in prominent categories, including Q2 in Biotechnology and Q2 in Pharmaceutical Science, reflecting its robust impact on the global scientific community. The journal aims to provide researchers, professionals, and students with high-quality articles that contribute significantly to the advancement of drug development and medicinal applications. Although it does not currently offer Open Access options, its rigorous peer-review process ensures that only the highest caliber research is published, making it a valuable resource for those seeking to stay at the forefront of pharmaceutical innovation.

Iranian Journal of Pharmaceutical Research

Championing excellence in pharmacological research and discovery.
Publisher: BRIEFLANDISSN: 1735-0328Frequency: 4 issues/year

Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.

AAPS Journal

Connecting Researchers and Innovators in Pharmaceutical Sciences.
Publisher: SPRINGERISSN: 1550-7416Frequency: 1 issue/year

AAPS Journal, published by Springer in the United States, is a leading peer-reviewed journal dedicated to the advancement of research in the field of Pharmaceutical Sciences. With an impressive Q1 rank in its category and a position within the 81st percentile of Scopus rankings, it serves as a vital resource for researchers and professionals seeking to disseminate impactful findings and innovative methodologies. The journal publishes high-quality original research, review articles, and technical reports aimed at addressing the multifaceted challenges in pharmacology, toxicology, and pharmaceutics. Operating under an Open Access model, AAPS Journal ensures broad dissemination of knowledge, contributing to the enhanced visibility and accessibility of research outputs. With a publication window spanning from 1999 to 2024, it continues to shape the future of pharmaceutical research and its applications. Researchers, students, and industry professionals will find a valuable repository of cutting-edge knowledge in this esteemed journal.

Pharmaceutical Sciences

Exploring innovative solutions in pharmaceutical sciences.
Publisher: TABRIZ UNIV MEDICAL SCIENCES, FAC PHARMACYISSN: 1735-403XFrequency: 4 issues/year

Pharmaceutical Sciences, an esteemed journal published by Tabriz University of Medical Sciences, Faculty of Pharmacy, serves as a crucial platform for the dissemination of pioneering research in the fields of pharmaceutical science, pharmacology, and toxicology. With an impact factor reflective of its substantial contribution to the scientific community, this open access journal has been accessible since 2012, ensuring that researchers, professionals, and students worldwide can engage with its rich content. Located in Iran, it has continually evolved, covering research from 2009 to 2024, and boasts impressive rankings in multiple Scopus categories, including Q3 in Pharmaceutical Science and Q2 in Pharmacology, Toxicology and Pharmaceutics. By bridging gaps between scientific inquiry and practical applications, Pharmaceutical Sciences is dedicated to advancing pharmaceutical knowledge and promoting innovative practices that address significant health challenges.

JOURNAL OF PHARMACEUTICAL SCIENCES

Unveiling the science behind effective therapies and innovations.
Publisher: ELSEVIER SCIENCE INCISSN: 0022-3549Frequency: 12 issues/year

The JOURNAL OF PHARMACEUTICAL SCIENCES, published by ELSEVIER SCIENCE INC, stands as a cornerstone in the field of pharmaceutical sciences, offering a platform for innovative research and advancements since its inception in 1961. With an impressive Scopus Rank of #36 out of 183 in the Pharmaceutical Science category, this journal is recognized for its commitment to disseminating high-quality, peer-reviewed studies that significantly contribute to the realms of pharmacology, toxicology, and pharmaceutics. Holding a 2023 Q2 category quartile, it attracts a diverse readership encompassing researchers, industry professionals, and students eager to advance their understanding and expertise. While the journal is not open access, it ensures valuable insights in every issue, making it an essential resource for those dedicated to the evolving landscape of pharmaceutical research. With an impact factor that reflects its relevance and influence, the JOURNAL OF PHARMACEUTICAL SCIENCES continues to shape the discourse in its domain, fostering innovation and collaboration among scholars worldwide.